Oseltamivir treatment and prophylaxis in a neonatal intensive care unit during a 2009 H1N1 influenza outbreak

Journal of Perinatology

Volumn 31, Issue 7, 2011, Pages 487-493

  Pannaraj, P S ^a   Tam, B ^b   Akan, D ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

antiviral; infant; infection; neonate; pandemic influenza

Indexed keywords

OSELTAMIVIR;

2009 H1N1 INFLUENZA; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY WEIGHT; CLINICAL ARTICLE; COMORBIDITY; DIARRHEA; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; GASTROINTESTINAL SYMPTOM; GESTATIONAL AGE; HEMATOCHEZIA; HUMAN; INFANT; INFECTION PREVENTION; LIVER FUNCTION TEST; MALE; MEDICAL RECORD REVIEW; NEUROLOGIC DISEASE; NEWBORN; NEWBORN INTENSIVE CARE; PAPULAR RASH; PREMATURITY; RETROSPECTIVE STUDY; SIDE EFFECT; VOMITING;

ANTIVIRAL AGENTS; COHORT STUDIES; DISEASE OUTBREAKS; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, PEDIATRIC; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE UNITS, NEONATAL; MALE; OSELTAMIVIR; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; URBAN POPULATION;

EID: 79959818315     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2010.159     Document Type: Article

References (28)

1. Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000; 342: 225-231. (Pubitemid 30058953)
2. Poehling KA, Edwards KM, Weinberg GA, Szilagyi P, Staat MA, Iwane MK et al. The underrecognized burden of influenza in young children. N Engl J Med 2006; 355: 31-40.
3. Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000; 342: 232-239. (Pubitemid 30058954)
4. O'Brien MA, Uyeki TM, Shay DK, Thompson WW, Kleinman K, McAdam A et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics 2004; 113: 585-593. (Pubitemid 38280802)
5. Ampofo K, Gesteland PH, Bender J, Mills M, Daly J, Samore M et al. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics 2006; 118: 2409-2417. (Pubitemid 46397581)
6. Chiu SS, Chan KH, Chen H, Young BW, Lim W, Wong WHS et al. Virologically confirmed population-based burden of hospitalization caused by influenza A and B among children in Hong Kong. Clin Infect Dis 2009; 49: 1016-1021.
7. Dao CN, Kamimoto L, Nowell M, Reingold A, Gershman K, Meek J et al. Adult hospitalizations for laboratory-positive influenza during the 2005=2006 through 2007-2008 seasons in the United States. J Infect Dis 2010; 202: 881-888.
8. Whitley RJ, Monto AS. Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents. J Infect Dis 2006; 194: S133-S138. (Pubitemid 44630957)
9. Principi N, Esposito S. Are we ready for universal influenza vaccination in paediatrics? Lancet Infect Dis 2004; 4: 75-83.
10. Groothuis JR, Levin MJ, Rabalais GP, Meiklejohn G, Lauer BA. Immunization of highrisk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics 1991; 87: 823-828.
11. Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, Riff D et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. JAMA 2000; 283: 1016-1024. (Pubitemid 30112215)
12. Oo C, Hill G, Dorr A, Liu B, Boellner S, Ward P. Pharmacokinetics of antiinfluenza prodrug oseltamivir in children aged 1-5 years. Eur J Clin Pharmacol 2003; 59: 411-415. (Pubitemid 37214948)
13. American Academy of Pediatrics Committee on Infectious Diseases. Antiviral therapy and prophylaxis for influenza in children. Pediatrics 2007; 119: 852-860.
14. Centers for Disease Control and Prevention. Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 433-435.
15. Centers for Disease Control and Prevention. Interim guidance on antiviral recommendations for patients with novel influenza A (H1N1) virus infection and their close contacts Available at http://www.cdc.gov/h1n1flu/recommendations. htm. Accessed on July 8, 2009.
16. Centers for Disease Control and Prevention. CDC protocol of realtime RTPCR for influenza A(H1N1). Available at: http://www.who.int/csr/resources/ publications/swineflu/CDCRealtimeRTPCR-SwineH1Assay-2009-20090430.pdf. Accessed on December 16, 2009.
17. Centers for Disease Control and Prevention. Interim Guidance on Antiviral Recommendations for Patients with Novel Influenza A (H1N1) Virus Infection and Their Close Contacts. Available at http://www.cdc.gov/h1n1flu/recommendations. htm. Accessed on July 8, 2009.
18. Centers for Disease Control and Prevention. Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) virus - United States, 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 826-829.
19. Roche Pharmaceuticals. 'Dear Healthcare Professional' letter , December 2003. Available at: http://www.fda.gov/downloads/Safety/MedWatch/ SafetyInformation/SafetyAlertsforHumanMedicalProducts/UCM169493.pdf. Accessed on July 8, 2009.
20. Okamoto S, Kamiya I, Kishida K, Shimakawa T, Fukui T, Morimoto T. Experience with oseltamivir for infants younger than 1 year old in Japan. Pediatr Infect Dis J 2005; 24: 575-576. (Pubitemid 40847541)
21. Tamura D, Miura T, Kikuchi Y. Oseltamivir phosphate in infants under 1 year of age with influenza infection. Pediatr Internat 2005; 47: 484. (Pubitemid 41169592)
22. Kimberlin DW, Shalabi M, Abzug MJ, Lang D, Jacobs RF, Storch G et al. Safety of oseltamivir compared with the adamantanes in children less than 12 months of age. Pediatr Infect Dis J 2010; 29: 195-198.
23. Siedler K, Skopnik H. Oseltamivir for treatment of influenza in Infants less than one year. Pediatr Infect Dis 2010; 29: 495-498.
24. Ginocchio CC, Zhang F, Manji R, Arora S, Bornfreund M, Falk L et al. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 2009; 45: 191-195.
25. Vasoo S, Stevens J, Singh K. Rapid antigen tests for diagnosis of pandemic (swine) influenza A/H1N1. Clin Infect Dis 2009; 49: 1090-1093.
26. Faix DJ, Sherman SS, Waterman SH. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 361: 728-729.
27. Sambol AR, Abdalhamid B, Lyden ER, Aden TA, Noel RK, Hinrichs SH. Use of rapid influenza diagnostic tests under field conditions as a screening tool during an outbreak of the 2009 novel influenza virus: practical considerations. J Clin Virol 2010; 47: 229-233.
28. Acosta EP, Jester P, Gail P, Wimmer J, Wade J, Whitley RJ et al. Oseltamivir dosing for influenza infection in premature neonates. J Infect Dis 2010; 202: 563-566.